West Pharmaceutical Services Inc.
WST | NYSE
$412.62
-$4.05 (-0.97%)
At close: Oct 30, 2026, 4:00 PM ET
$420.74
+$8.12 (+1.97%)
Pre-market:
Nov 2, 2026, 7:01 AM ET
Company Profile
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Key Executives
| Name | Position |
|---|---|
| Eric Green | Non-Independent Chair of the Board, President & Chief Executive Officer |
| Michel Lagarde | President, CEO & Director |
| Devesh Mathur | Senior Vice President & Chief Technology Officer |
| Robert W. McMahon | Senior Vice President & Chief Financial Officer |
| Aileen Ruff-Patry | President of Contract Manufacturing |
| Andy Polywacz | President of Integrated Systems |
| Annette F. Favorite | Chief Human Resources Officer & Senior Vice President |
| Chad R. Winters | Vice President of Finance & Chief Accounting Officer |
| Don O'Callaghan | President of Drug Delivery Devices |
| John Sweeney | Vice President of Investor Relations |
| Kathy DePadua | Senior Vice President and Chief Quality & Regulatory Officer |
| Michele Polinsky | Vice President of Global Communications |
| Norman Finch | Senior VP, General Counsel & Corporate Secretary |
| Rudy Poussot | Senior Vice President of Strategy & Corporate Development |
| Shane Campbell | SVP & Chief Proprietary Segment Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 02, 2026 | 4 | Filing |
| Sep 15, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Sep 10, 2026 | 3 | Filing |
| Aug 12, 2026 | 4 | Filing |
| Aug 06, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 23, 2026 | 10-Q | Quarterly Report |
| Jul 23, 2026 | 8-K | Current Report |
| Jul 14, 2026 | 8-K | Current Report |
West Pharmaceutical Services Inc.
| Country | United States |
| IPO Date | Mar 17, 1980 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 10,800 |
| CEO | Michel Lagarde |
Contact Details
530 Herman O. West Drive Exton,
Pennsylvania 19341-1147 United States
Stock Details
| Ticker Symbol | WST |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000105770 |
| CUSIP Number | 955306105 |
| ISIN Number | US9553061055 |
| SIC Code | 3060 |
Recent News
- 2 days ago / marketbeat.comWhat West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call
- 3 days ago / seekingalpha.comWest Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript
- 3 days ago / zacks.comWest Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook Raised
- 4 days ago / zacks.comCompared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics
- 4 days ago / zacks.comWest Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
- 4 days ago / prnewswire.comWest Reports Third-Quarter 2026 Results
- 5 days ago / zacks.comWest Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
- 6 days ago / zacks.comWST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?
- 12 days ago / zacks.comReasons to Add West Pharmaceutical Stock to Your Portfolio Now
- 14 days ago / prnewswire.comWest Declares Quarterly Dividend
Add to Watchlist
Select watchlists to add or remove WST